Denali Therapeutics Inc. (NASDAQ:DNLI) shares fell to a low of $72.87 before closing at $74.81. Intraday shares traded counted 0.64 million, which was -25.84% lower
Denali Therapeutics Inc. (NASDAQ:DNLI) previous close was $72.50 while the outstanding shares total 120.89M. The firm has a beta of 1.90, a 12-month trailing P/E
Denali Therapeutics Inc. (NASDAQ:DNLI) has a beta of 1.90, a 12-month trailing P/E ratio of 471.04. The stock’s Relative Strength Index (RSI) is 61.48, with
Denali Therapeutics Inc. (NASDAQ:DNLI) shares traded higher over the last trading session, gaining 5.04% on 05/25/21. The shares fell to a low of $60.50 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
